Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/v61EJG71Zl
International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2022 – Jan 2025Where it's discussed
-
X / Twitter12 posts
-
YouTube2 videos
-
Blogs2 articles
AI synopsis
What people are saying
The overall discussions reflect a neutral stance, with participants referencing the publication's content without strong opinions, such as phrases like 'interpretation of guidelines' and simple hashtags. The tone remains somewhat reserved, emphasizing understanding rather than challenging or endorsing the recommendations, which explains the moderate engagement and interest scores.
Most discussions acknowledge the guidelines but do not express strong disagreement or support, indicating neutrality.
Participants show a modest level of curiosity, primarily focusing on understanding the guidelines' recommendations.
Comments often include brief reflections and mentions of the article, suggesting some level of interaction without in-depth analysis.
The discussions seem to have limited influence on practice or policy changes, reflecting a cautious or neutral stance.
Abstract in brief
- International guidelines suggest that IVIG is not recommended for routine treatment of Rh or ABO-mediated hemolytic disease of the newborn (HDN), which can cause serious health issues.
- While exchange transfusions (ET) are effective but invasive and risky, IVIG might be an alternative in severe cases or when ET isn't available, but current evidence is unclear about its safety and effectiveness.
- More high-quality research is needed to determine the best use of IVIG in managing HDN, especially in severe cases where traditional treatments like ET are imminent or unavailable.
Top posts
Most liked on X and BlueskyInterpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/syDPzSSxdv
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/p3i0sM4zJo
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/fBLlHxnw0v
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/LUgkAQjZfB
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/sZX9uROZ4M
All mentions
Neonatal Hemolytic Disease Management Insights from Dr Tim Bahr
Bethany and Molly interview Dr Timothy Bahr, a neonatologist specializing in neonatal hematology, about neonatal HDFN. They cover challenges, treatment options, and recent research, including IVIG's role and hemolysis…
Neonatal Hemolytic Disease Management and Treatment Guidelines
Bethany and Molly interview Dr Timothy Bahr, a neonatologist specializing in neonatal hematology, about your questions on neonatal Hemolytic Disease of the Newborn, including blood preparation for exchange transfusions…
RT @neo_papers: Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic…
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/p3i0sM4zJo
RT @neo_papers: Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic…
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/fBLlHxnw0v
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/LUgkAQjZfB
RT @neo_papers: Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic…
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/v61EJG71Zl
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/sZX9uROZ4M
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/B12TQguF4q
RT @neo_papers: Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic…
RT @neo_papers: Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic…
Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn" #NeoPapers #neoTwitter https://t.co/syDPzSSxdv
NP
NT
AB